StonvexLoading…
StonvexStonvexStonvexCore line items from NKTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $55.23M | $98.43M | $90.12M | $92.06M |
Operating Income | $-140.10M | $-105.20M | $-263.68M | $-376.17M |
Net Income | $-164.08M | $-118.96M | $-276.06M | $-368.20M |
EPS (Diluted) | $-9.73 | $-8.68 | $-1.45 | $-1.97 |
Total Assets | $280.41M | $303.85M | $398.03M | $710.60M |
Total Liabilities | $190.57M | $243.11M | $267.05M | $343.96M |
Cash & Equivalents | $15.12M | $44.25M | $35.28M | $88.23M |
Free Cash Flow OCF − CapEx | $-208.68M | $-177.18M | $-193.47M | $-309.68M |
Shares Outstanding | 20.38M | 12.39M | 191.38M | 188.56M |